We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Regulatory News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

4 Dec 2018 13:08

RNS Number : 4088J
Diurnal Group PLC
04 December 2018
 

4 December 2018

 

Diurnal Group plc

("Diurnal" or the "Company")

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them in accordance with the Market Abuse Regulations

 

On 4 December 2018, Diurnal issued a total of 1,217,259 par value options over ordinary shares of 5 pence in the Company under the Diurnal Group plc Long Term Incentive Plan (the "Plan"), of which the following were issued to persons discharging managerial responsibilities ("PDMR"):

 

PDMR

Total number of shares awarded

Type of awards

Martin Whitaker

255,105

Performance share award

Richard Bungay

204,083

Performance share award

Richard Ross

71,743

 

 

The performance share awards will ordinarily vest no earlier than the third anniversary of their grant subject to the grantee's continued service and to the extent to which the performance conditions set for the awards are satisfied. Such awards may potentially vest until the fifth anniversary of their grant date. The awards were granted under award agreements that incorporated the terms of the Plan. No consideration is due to be payable on vesting.

 

Details of the full notifications received by the Company are set out below:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 Martin Whitaker

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Diurnal Group plc

b)

 

LEI

 

213800I2HNUNZN1LDH29

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Grant of award of options under the Diurnal Group plc Long Term Incentive Plan over Ordinary shares of 5p each

 

 

Identification code

Ordinary shares: GB00BDB6Q760

 

 

b)

 

Nature of the transaction

 

Grant of awards under the Diurnal Group plc Long Term Incentive Plan as par value options as follows:

 

Performance share award over 255,105 ordinary shares.

 

The performance share award will ordinarily vest no earlier than the third anniversary of its grant subject to continued service and to the extent to which the performance conditions set for the awards are satisfied. Such award may potentially vest until the fifth anniversary of its grant date.

 

No consideration is due to be payable on vesting.

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

Nil exercise price

255,105

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

Award over 255,105 ordinary shares.

 

 

- Price

Nil price payable for grant and upon exercise

 

 

e)

 

Date of the transaction

 

4 December 2018

f)

 

Place of the transaction

 

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 Richard Bungay

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Diurnal Group plc

b)

 

LEI

 

213800I2HNUNZN1LDH29

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Grant of award of options under the Diurnal Group plc Long Term Incentive Plan over Ordinary shares of 5p each

 

 

Identification code

Ordinary shares: GB00BDB6Q760

 

 

b)

 

Nature of the transaction

 

Grant of awards under the Diurnal Group plc Long Term Incentive Plan as par value options as follows:

 

Performance share award over 204,083 ordinary shares.

 

The performance share award will ordinarily vest no earlier than the third anniversary of its grant subject to continued service and to the extent to which the performance conditions set for the awards are satisfied. Such award may potentially vest until the fifth anniversary of its grant date.

 

No consideration is due to be payable on vesting.

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

Nil exercise price

204,083

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

Award over 204,083 ordinary shares.

 

 

- Price

Nil price payable for grant and upon exercise

 

 

e)

 

Date of the transaction

 

4 December 2018

f)

 

Place of the transaction

 

Outside a trading venue

 

 

Details of the person discharging managerial responsibilities / person closely associated

 

Name

 

 Richard Ross

Reason for the notification

 

Position/status

 

Chief Scientific Officer

Initial notification /Amendment

 

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

Name

 

Diurnal Group plc

LEI

 

213800I2HNUNZN1LDH29

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Description of the financial instrument, type of instrument

Grant of award of options under the Diurnal Group plc Long Term Incentive Plan over Ordinary shares of 5p each

 

 

Identification code

Ordinary shares: GB00BDB6Q760

 

 

Nature of the transaction

 

Grant of awards under the Diurnal Group plc Long Term Incentive Plan as par value options as follows:

 

Performance share award over 71,743 ordinary shares.

 

The performance share award will ordinarily vest no earlier than the third anniversary of its grant subject to continued service and to the extent to which the performance conditions set for the awards are satisfied. Such award may potentially vest until the fifth anniversary of its grant date.

 

No consideration is due to be payable on vesting.

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

Nil exercise price

71,743

 

 

 

 

 

 

Aggregated information

 

 

 

- Aggregated volume

Award over 71,743 ordinary shares.

 

 

- Price

Nil price payable for grant and upon exercise

 

 

Date of the transaction

 

4 December 2018

Place of the transaction

 

Outside a trading venue

 

 

For further information, please visit www.diurnal.co.uk or contact:

 

 

Diurnal Group plc

+44 (0)20 3727 1000

Martin Whitaker, Chief Executive Officer

 

Richard Bungay, Chief Financial Officer

 

 

 

Panmure Gordon (UK) Limited (Nominated Adviser and Joint Broker)

+44 (0) 20 7886 2500

Corporate Finance: Freddy Crossley, Emma Earl

 

Corporate Broking: James Stearns

 

 

 

Cantor Fitzgerald Europe (Joint Broker)

+44 (0)20 7894 7000

Corporate Finance: Phil Davies, Will Goode, Michael Boot

 

Healthcare Equity Sales: Andrew Keith

 

 

 

FTI Consulting (Media and Investor Relations)

+44 (0)20 3727 1000

Simon Conway

 

Victoria Foster Mitchell

 

 

 

Notes to Editors

 

About Diurnal Group plc

Founded in 2004, Diurnal is a UK-based specialty pharma company developing high quality products for the global market for the life-long treatment of chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.

 

For further information about Diurnal, please visit www.diurnal.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFSUFELFASELE
Date   Source Headline
2nd Nov 20227:00 amRNSCancellation - Diurnal Group plc
1st Nov 20229:20 amRNSDIURNAL SCHEME OF ARRANGEMENT BECOMES EFFECTIVE
1st Nov 20228:59 amRNSNotification of major holdings
1st Nov 20227:30 amRNSSuspension - Diurnal Group plc
28th Oct 20224:52 pmRNSEXERCISE OF OPTIONS
28th Oct 20222:22 pmRNSCOURT SANCTION OF SCHEME OF ARRANGEMENT
28th Oct 20221:26 pmRNSForm 8.3 - Diurnal Group plc
27th Oct 20225:30 pmRNSDiurnal Group
24th Oct 20229:30 amRNSForm 8.5 (EPT/RI) - Diurnal Group plc
21st Oct 20221:17 pmRNSRESULTS OF COURT MEETING AND GENERAL MEETING
18th Oct 20224:49 pmRNSForm 8.5 (EPT/RI)
12th Oct 202212:30 pmRNSStandard form for notification of major holdings
11th Oct 20223:24 pmRNSForm 8.3 - Diurnal Group plc
11th Oct 20228:25 amRNSForm 8.3 - Diurnal Group PLC
11th Oct 20227:00 amRNSBlock Admission Application
7th Oct 20227:00 amRNSAWMSG recommends Efmody for CAH in Wales
5th Oct 20223:15 pmRNSForm 8.3 - Diurnal Group plc
27th Sep 20223:26 pmRNSForm 8.3 - Diurnal Group plc
27th Sep 20221:33 pmRNSForm 8.3 - Diurnal Group plc
27th Sep 202212:43 pmRNSForm 8.3 - Diurnal Group PLC
27th Sep 20229:33 amRNSForm 8.5 (EPT/RI) - Diurnal Group plc
26th Sep 202211:01 amRNSForm 8.5 (EPT/RI) - Diurnal Group PLC
26th Sep 20229:32 amRNSForm 8.3 - [DIURNAL GROUP PLC]
23rd Sep 20223:01 pmRNSForm 8.3 - Diurnal Group plc
23rd Sep 20229:28 amRNSCorrection: Publication of Scheme Document
23rd Sep 20228:56 amRNSForm 8.5 (EPT/RI) - Diurnal Group plc
23rd Sep 20227:00 amRNSPublication of Scheme Document
23rd Sep 20227:00 amRNSPublication of Scheme Document
21st Sep 202210:20 amRNSForm 8.5 (EPT/RI) - Diurnal Group plc
20th Sep 20222:57 pmRNSForm 8.3 - Diurnal Group plc
20th Sep 20228:37 amRNSForm 8.5 (EPT/RI) - Diurnal Group plc
16th Sep 202210:47 amRNSForm 8.3 - [DIURNAL GROUP PLC]
16th Sep 20229:01 amRNSForm 8.3 - [DIURNAL GROUP PLC]
16th Sep 20228:53 amRNSForm 8.5 (EPT/RI) - Diurnal Group plc
15th Sep 20229:31 amRNSForm 8.5 (EPT/RI) - Diurnal Group plc
14th Sep 20229:00 amRNSForm 8.5 (EPT/RI) - Diurnal Group plc
14th Sep 20227:00 amRNSInterim Results
13th Sep 20228:32 amRNSForm 8.5 (EPT/RI) - Diurnal Group plc
12th Sep 20222:57 pmRNSForm 8.3 - Diurnal Group plc
12th Sep 20221:40 pmRNSForm 8.3 - Diurnal Group Plc
12th Sep 20229:42 amRNSForm 8.5 (EPT/RI) - Diurnal Group plc
9th Sep 20223:04 pmRNSForm 8.3 - Diurnal Group plc
8th Sep 20225:56 pmRNSForm 8.3 - IPG - Diurnal Group PLC
8th Sep 202212:24 pmRNSResignation of Joint Corporate Broker
8th Sep 202212:00 pmRNSForm 8.5 (EPT/RI) - Diurnal Group plc
8th Sep 202210:54 amRNSForm 8.3 - Diurnal Group PLC
8th Sep 202210:47 amRNSForm 8.3 - Diurnal Group PLC
8th Sep 20229:58 amRNSForm 8.5 (EPT/RI) - Diurnal Group plc
7th Sep 20222:58 pmRNSForm 8.3 - Diurnal Group plc
7th Sep 20222:08 pmRNSStandard form for notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.